Sisto Perdonà

Summary

Country: Italy

Publications

  1. ncbi request reprint Role of dynamic sentinel node biopsy in penile cancer: our experience
    S Perdona
    Department of Urology, IRCCS, National Cancer Institute, G Pascale Foundation, Naples, Italy
    J Surg Oncol 93:181-5. 2006
  2. ncbi request reprint Renal cell carcinoma with solitary toe metastasis
    Sisto Perdonà
    Department of Urology, National Cancer Institute, I R C C S Fondazione G Pascale, Naples, Italy
    Int J Urol 12:401-4. 2005
  3. ncbi request reprint Efficacy of tamoxifen and radiotherapy for prevention and treatment of gynaecomastia and breast pain caused by bicalutamide in prostate cancer: a randomised controlled trial
    Sisto Perdonà
    Department of Urology, National Tumour Institute, G Pascale Foundation IRCSS, Naples, Italy
    Lancet Oncol 6:295-300. 2005
  4. doi request reprint Paclitaxel in pretreated metastatic penile cancer: final results of a phase 2 study
    Giuseppe Di Lorenzo
    Genitourinary Oncology and Rare Cancer Center, Federico II University, Naples, Italy
    Eur Urol 60:1280-4. 2011
  5. doi request reprint Cisplatin and 5-fluorouracil in inoperable, stage IV squamous cell carcinoma of the penis
    Giuseppe Di Lorenzo
    Genitourinary Cancer Section and Rare Cancer Center, University Federico II, Naples, Italy
    BJU Int 110:E661-6. 2012
  6. ncbi request reprint Dynamic sentinel node biopsy in clinically node-negative penile cancer versus radical inguinal lymphadenectomy: a comparative study
    Sisto Perdonà
    Department of Urology, National Cancer Institute, Naples, Italy
    Urology 66:1282-6. 2005
  7. doi request reprint Phase II trial of cisplatin plus prednisone in docetaxel-refractory castration-resistant prostate cancer patients
    Carlo Buonerba
    Department of Endocrinology and Medical Oncology, Genitourinary Cancer Section, University Federico II, Naples, Italy
    Cancer Chemother Pharmacol 67:1455-61. 2011
  8. pmc Prostate Health Index (Phi) and Prostate Cancer Antigen 3 (PCA3) significantly improve prostate cancer detection at initial biopsy in a total PSA range of 2-10 ng/ml
    Matteo Ferro
    Urology Unit, University Federico II, Naples, Italy
    PLoS ONE 8:e67687. 2013
  9. doi request reprint Combined magnetic resonance spectroscopy and dynamic contrast-enhanced imaging for prostate cancer detection
    Sisto Perdonà
    Urology Section, Istituto Nazionale Tumori, Fondazione G Pascale, Naples, Italy
    Urol Oncol 31:761-5. 2013
  10. pmc Tumour biomarkers: homeostasis as a novel prognostic indicator
    Michela Falco
    Struttura Semplice Dipartimentale Sperimentazione Animale, Istituto Nazionale Tumori Fondazione G Pascale, IRCCS, Via Mariano Semmola, 80131 Naples, Italy
    Open Biol 6:. 2016

Collaborators

Detail Information

Publications35

  1. ncbi request reprint Role of dynamic sentinel node biopsy in penile cancer: our experience
    S Perdona
    Department of Urology, IRCCS, National Cancer Institute, G Pascale Foundation, Naples, Italy
    J Surg Oncol 93:181-5. 2006
    ..We report our initial experience with a relatively new technique, the so-called "dynamic sentinel node biopsy", in patients with penile cancer...
  2. ncbi request reprint Renal cell carcinoma with solitary toe metastasis
    Sisto Perdonà
    Department of Urology, National Cancer Institute, I R C C S Fondazione G Pascale, Naples, Italy
    Int J Urol 12:401-4. 2005
    ..Thus, metastatic RCC should be included in the differential diagnosis of all enlarging cutaneous nodules, wherever they develop...
  3. ncbi request reprint Efficacy of tamoxifen and radiotherapy for prevention and treatment of gynaecomastia and breast pain caused by bicalutamide in prostate cancer: a randomised controlled trial
    Sisto Perdonà
    Department of Urology, National Tumour Institute, G Pascale Foundation IRCSS, Naples, Italy
    Lancet Oncol 6:295-300. 2005
    ..We aimed to compare tamoxifen with radiotherapy for prevention and treatment of gynaecomastia, breast pain, or both during bicalutamide monotherapy for prostate cancer...
  4. doi request reprint Paclitaxel in pretreated metastatic penile cancer: final results of a phase 2 study
    Giuseppe Di Lorenzo
    Genitourinary Oncology and Rare Cancer Center, Federico II University, Naples, Italy
    Eur Urol 60:1280-4. 2011
    ..Previously published preliminary findings showed promising activity of paclitaxel in chemotherapy-pretreated metastatic penile cancer...
  5. doi request reprint Cisplatin and 5-fluorouracil in inoperable, stage IV squamous cell carcinoma of the penis
    Giuseppe Di Lorenzo
    Genitourinary Cancer Section and Rare Cancer Center, University Federico II, Naples, Italy
    BJU Int 110:E661-6. 2012
    ..Neutropenia was the most important grade 3-4 side effect observed, occurring in 20% of patients. These data provide confirmation that such a combination regimen is moderately effective and well tolerated in patients with SCCP...
  6. ncbi request reprint Dynamic sentinel node biopsy in clinically node-negative penile cancer versus radical inguinal lymphadenectomy: a comparative study
    Sisto Perdonà
    Department of Urology, National Cancer Institute, Naples, Italy
    Urology 66:1282-6. 2005
    ..To evaluate the reliability and morbidity of dynamic sentinel node biopsy compared with radical inguinal lymphadenectomy (RIL) in the treatment of selected patients with squamous cell penile carcinoma...
  7. doi request reprint Phase II trial of cisplatin plus prednisone in docetaxel-refractory castration-resistant prostate cancer patients
    Carlo Buonerba
    Department of Endocrinology and Medical Oncology, Genitourinary Cancer Section, University Federico II, Naples, Italy
    Cancer Chemother Pharmacol 67:1455-61. 2011
    ..Docetaxel represents the first-line treatment for castration-resistant prostate cancer (CRPC). New therapeutic options are needed for subsequent lines of therapy in CRPC patients...
  8. pmc Prostate Health Index (Phi) and Prostate Cancer Antigen 3 (PCA3) significantly improve prostate cancer detection at initial biopsy in a total PSA range of 2-10 ng/ml
    Matteo Ferro
    Urology Unit, University Federico II, Naples, Italy
    PLoS ONE 8:e67687. 2013
    ..001 and p = 0.01, respectively). In conclusion, both phi and PCA3 comparably increase the accuracy in predicting the presence of PCa in total PSA range 2-10 ng/ml at initial biopsy, outperforming currently used %fPSA. ..
  9. doi request reprint Combined magnetic resonance spectroscopy and dynamic contrast-enhanced imaging for prostate cancer detection
    Sisto Perdonà
    Urology Section, Istituto Nazionale Tumori, Fondazione G Pascale, Naples, Italy
    Urol Oncol 31:761-5. 2013
    ..The use of magnetic resonance spectroscopy imaging (MRSI) and dynamic contrast enhanced magnetic resonance imaging (DCE-MRI) have emerged as a valid diagnostic tools for prostate cancer (CaP)...
  10. pmc Tumour biomarkers: homeostasis as a novel prognostic indicator
    Michela Falco
    Struttura Semplice Dipartimentale Sperimentazione Animale, Istituto Nazionale Tumori Fondazione G Pascale, IRCCS, Via Mariano Semmola, 80131 Naples, Italy
    Open Biol 6:. 2016
    ....
  11. ncbi request reprint The emerging role of obesity, diet and lipid metabolism in prostate cancer
    Matteo Ferro
    Department of Urology, European Institute of Oncology IEO, Milan, Italy
    Future Oncol . 2016
    ..This review explores the available clinical as well as biological evidence supporting the relationship between obesity, diet, alteration in metabolic pathways and prostate cancer...
  12. doi request reprint Predicting prostate biopsy outcome: prostate health index (phi) and prostate cancer antigen 3 (PCA3) are useful biomarkers
    Matteo Ferro
    Department of Urology, University of Naples Federico II, Naples, Italy
    Clin Chim Acta 413:1274-8. 2012
    ..In conclusion, %p2PSA, phi and PCA3 may predict a diagnosis of PCa in men undergoing their first prostate biopsy. PCA3 score is more useful in discriminating between HGPIN and non-cancer...
  13. ncbi request reprint Vesicourethral anastomosis during radical retropubic prostatectomy: does the number of sutures matter?
    Luigi Gallo
    Department of Urology, National Cancer Institute Pascale Foundation, Naples, Italy
    Urology 69:547-51. 2007
    ..To prospectively evaluate the outcome of radical retropubic prostatectomy using three different techniques of vesicourethral anastomosis (VUA), with a different number of sutures used during this surgical step...
  14. doi request reprint Combination of bevacizumab and docetaxel in docetaxel-pretreated hormone-refractory prostate cancer: a phase 2 study
    Giuseppe Di Lorenzo
    Department of Clinical and Molecular Oncology, Federico II University, Naples, Italy
    Eur Urol 54:1089-94. 2008
    ..No agents are approved for second-line therapy in HRPC, but common standard practice for the oncologists is to treat patients also after docetaxel failure...
  15. ncbi request reprint Quality of life in women with multiple sclerosis and overactive bladder syndrome
    Giuseppe Quarto
    Division of Urology, Second University of Naples, Naples, Italy
    Int Urogynecol J Pelvic Floor Dysfunct 18:189-94. 2007
    ..In conclusion, OAB symptoms have a major impact on the QoL in patients with MS, even if their perception of QoL impairment remains limited. Optimal management in these subjects should include a complete UDS assessment...
  16. doi request reprint Low serum total testosterone level as a predictor of upstaging and upgrading in low-risk prostate cancer patients meeting the inclusion criteria for active surveillance
    Matteo Ferro
    Department of Urology, European Institute of Oncology, Via Ripamonti, Milan, Italy
    Oncotarget . 2016
    ....
  17. ncbi request reprint Bladder-sparing, combined-modality approach for muscle-invasive bladder cancer: a multi-institutional, long-term experience
    Sisto Perdonà
    Comprehensive Urology Unit, National Tumor Institute, G Pascale Foundation, Naples, Italy
    Cancer 112:75-83. 2008
    ..The authors evaluated their long-term experience with combined-modality, conservative treatment in patients with muscle-invasive bladder cancer...
  18. ncbi request reprint Gyrus bipolar versus standard monopolar transurethral resection of the prostate: a randomized prospective trial
    Marco De Sio
    Department of Urology, Seconda Universita di Napoli, Naples, Italy
    Urology 67:69-72. 2006
    ..To compare bipolar plasmakinetic (PK) with standard monopolar transurethral resection of the prostate (TURP)...
  19. pmc Mouse Models in Prostate Cancer Translational Research: From Xenograft to PDX
    Domenica Rea
    Animal Facility Unit, Department of Experimental Oncology, Istituto Nazionale per lo Studio e la Cura dei Tumori Fondazione G Pascale, IRCCS, 80131 Naples, Italy
    Biomed Res Int 2016:9750795. 2016
    ..Today the development of preclinical models in vitro and in vivo is necessary in order to obtain increasingly reliable answers before reaching phase III of the drug discovery. ..
  20. pmc Urotensin II receptor determines prognosis of bladder cancer regulating cell motility/invasion
    Renato Franco
    Department of Biochemistry, Biophysics and General Pathology, Second University of Naples, Naples, Italy
    J Exp Clin Cancer Res 33:48. 2014
    ..The aim of this study is to evaluate if UTR expression can discriminate between NMIBC and MIBC and predict the risk of relapses in NMIBCs...
  21. doi request reprint Chondroitin sulphate enhances the antitumor activity of gemcitabine and mitomycin-C in bladder cancer cells with different mechanisms
    Matteo Ferro
    Department of Urology, University Federico II, Naples, Italy
    Oncol Rep 27:409-15. 2012
    ..In conclusion, in the human bladder cancer cell line HT-1376 pharmacological combination of CS with GEM or MMC resulted in a strong synergism on cell growth inhibition...
  22. doi request reprint Activity and toxicity of paclitaxel in pretreated metastatic penile cancer patients
    Giuseppe Di Lorenzo
    University Federico II, Naples, Italy
    Anticancer Drugs 20:277-80. 2009
    ..Paclitaxel is well tolerated and associated with promising efficacy. Further trials, also in a neoadjuvant setting, are needed to corroborate our preliminary findings...
  23. doi request reprint Gemcitabine versus bacille Calmette-Guérin after initial bacille Calmette-Guérin failure in non-muscle-invasive bladder cancer: a multicenter prospective randomized trial
    Giuseppe Di Lorenzo
    Department of Molecular and Clinical Endocrinology and Oncology, Federico II University, Naples, Italy
    Cancer 116:1893-900. 2010
    ..The efficacy of intravesical gemcitabine was evaluated compared with repeated administration of bacille Calmette-Guérin (BCG) after BCG failure in high-risk, non-muscle-invasive bladder cancer (BC)...
  24. pmc Modified Glasgow Prognostic Score is Associated With Risk of Recurrence in Bladder Cancer Patients After Radical Cystectomy: A Multicenter Experience
    Matteo Ferro
    From the Division of Urology, European Institute of Oncology, Milan, Italy MF, OD, DB, AC, DVM, GM, AB Department of Urology, Iuliu Hatieganu University of Medicine and Pharmacy, Cluj Napoca, Romania OD Genitourinary Cancer Section, Medical Oncology Division, University Federico II, Napoli, Italy CB, GD, SD Division of Urology, University Federico II, Naples, Italy MC, VM Department of Public Health, University Federico II, Naples, Italy DB Urology Institute, University Hospitals, Cleveland, OH, USA RA Department of Biochemistry, Biophysics and General Pathology, Second University of Naples, Naples, Italy MC Department of Urology, University of Bologna, S Orsola Malpighi Hospital, Bologna, Italy MB Division of Urology, University La Sapienza, Rome, Italy ED
    Medicine (Baltimore) 94:e1861. 2015
    ..In conclusion, the mGPS is an easily measured and inexpensive prognostic marker that was significantly associated with RFS in UBC patients...
  25. doi request reprint Prostate health index vs percent free prostate-specific antigen for prostate cancer detection in men with "gray" prostate-specific antigen levels at first biopsy: systematic review and meta-analysis
    Dario Bruzzese
    Department of Public Health, University Federico II, Naples, Italy
    Transl Res 164:444-51. 2014
    ..81 (95% CI, 2.19-3.6; P < 0.0001). In conclusion, PHI instead of %fPSA as a reflex test in men with tPSA "gray" levels is a better predictor of positive first biopsy and can offer a reduction in unnecessary biopsies...
  26. pmc Long non-coding RNA containing ultraconserved genomic region 8 promotes bladder cancer tumorigenesis
    Michele Olivieri
    Institute of Genetics and Biophysics A Buzzati Traverso, National Research Council CNR, Naples, Italy
    Oncotarget 7:20636-54. 2016
    ....
  27. pmc Pazopanib in Metastatic Renal Cancer: A "Real-World" Experience at National Cancer Institute "Fondazione G. Pascale"
    Sabrina C Cecere
    Division of Medical Oncology, Department of Uro Gynaecological Oncology, Istituto Nazionale Tumori IRCCS Fondazione G Pascale, Naples, Italy
    Front Pharmacol 7:287. 2016
    ....
  28. doi request reprint High levels of GPR30 protein in human testicular carcinoma in situ and seminomas correlate with low levels of estrogen receptor-beta and indicate a switch in estrogen responsiveness
    Francesca Boscia
    Dipartimento di Neuroscienze e Scienze Riproduttive ed Odontostomatologiche, Universita di Napoli Federico II, Naples, Italy
    J Cell Physiol 230:1290-7. 2015
    ....
  29. ncbi request reprint Management of gynaecomastia in patients with prostate cancer: a systematic review
    Giuseppe Di Lorenzo
    Department of Endocrinology and Molecular and Clinical Oncology, Second University Naples, Naples, Italy
    Lancet Oncol 6:972-9. 2005
    ..In this review, management options for gynaecomastia caused by hormonal manipulation in patients with prostate cancer are discussed...
  30. doi request reprint The role of short frenulum and the effects of frenulectomy on premature ejaculation
    Luigi Gallo
    Studio Urologico Gallo, Department of Andrology, Naples, Italy
    J Sex Med 7:1269-76. 2010
    ..The role of short frenulum and the effects of frenulectomy on premature ejaculation (PE) were never investigated...
  31. ncbi request reprint Efficacy of IDIProst® Gold, a formulation containing Serenoa repens, Crocus sativus and PMBE, in men with concomitant LUTS and ED
    Giuseppe Quarto
    U O di Urologia I N T Fondazione Pascale di Napoli, Naples, Italy
    Minerva Urol Nefrol . 2016
    ....
  32. pmc Axitinib after Sunitinib in Metastatic Renal Cancer: Preliminary Results from Italian "Real-World" SAX Study
    Carmine D'Aniello
    Oncology Unit, A O R N dei COLLI Ospedali Monaldi Cotugno CTO, Naples, Italy
    Front Pharmacol 7:331. 2016
    ..7 months (95% CI 18.4-51.0 months). Our results are consistent with the available literature; this retrospective analysis confirms that Axitinib is effective and safe in routine clinical practice...
  33. doi request reprint The stress hormone norepinephrine increases migration of prostate cancer cells in vitro and in vivo
    Antonio Barbieri
    Animal Facility Unit, National Institute of Tumours of Naples Pascale, Naples, Italy
    Int J Oncol 47:527-34. 2015
    ....
  34. doi request reprint Current applications of near-infrared fluorescence imaging in robotic urologic surgery: a systematic review and critical analysis of the literature
    Riccardo Autorino
    Department of Urology, Glickman Urological and Kidney Institute, Cleveland Clinic, Cleveland, OH Urology Unit, Second University of Naples, Naples, Italy Electronic address
    Urology 84:751-9. 2014
    ..Whether the added cost is justified by better outcomes remains to be determined. ..
  35. ncbi request reprint The use of tamsulosin in the medical treatment of ureteral calculi: where do we stand?
    Riccardo Autorino
    Department of Urology, Second University, Naples, Italy
    Urol Res 33:460-4. 2005
    ..This selective alpha-blocker should therefore be included in the pharmacological regimen of patients when a conservative approach is considered in the treatment of ureteral lithiasis...